21 related articles for article (PubMed ID: 14993813)
1. Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes.
Kumar R; Yadav N; Lavilla R; Blasi D; Quintana J; Brea JM; Loza MI; Mestres J; Bhandari M; Arora R; Kakkar R; Prasad AK
Mol Divers; 2017 Aug; 21(3):533-546. PubMed ID: 28444482
[TBL] [Abstract][Full Text] [Related]
2. Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes.
Xia Z; Wang M; Zou S; Chen R
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):211-6. PubMed ID: 22161476
[TBL] [Abstract][Full Text] [Related]
3. Identification of clinically used drugs that activate pregnane X receptors.
Shukla SJ; Sakamuru S; Huang R; Moeller TA; Shinn P; Vanleer D; Auld DS; Austin CP; Xia M
Drug Metab Dispos; 2011 Jan; 39(1):151-9. PubMed ID: 20966043
[TBL] [Abstract][Full Text] [Related]
4. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
Niwa T; Shiraga T; Hashimoto T; Kagayama A
Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
[TBL] [Abstract][Full Text] [Related]
6. Effect of probucol on cytochrome P450 activities in human liver microsomes.
Umehara K; Shimokawa Y; Miyamoto G
Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421
[TBL] [Abstract][Full Text] [Related]
7. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug.
Niwa T; Inoue S; Shiraga T; Takagi A
Biol Pharm Bull; 2005 Jan; 28(1):188-91. PubMed ID: 15635191
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.
Umehara K; Shimokawa Y; Miyamoto G
Biol Pharm Bull; 2002 May; 25(5):682-5. PubMed ID: 12033517
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease.
Tanaka E
J Clin Pharm Ther; 1998 Jun; 23(3):161-70. PubMed ID: 9831966
[TBL] [Abstract][Full Text] [Related]
10. Genetic factors influencing the metabolism of tolbutamide.
Back DJ; Orme ML
Pharmacol Ther; 1989; 44(2):147-55. PubMed ID: 2519343
[No Abstract] [Full Text] [Related]
11. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes.
Niwa T; Shiraga T; Hashimoto T; Kagayama A
Biol Pharm Bull; 2004 Mar; 27(3):415-7. PubMed ID: 14993813
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]